Visualization of Parkinson’s disease (PD) development may now be possible by identifying dopaminergic nigrosomes, or the lack thereof, according to a study published Aug. 6 in Neurology

The 2013 World Molecular Imaging Congress (WMIC) held Sept. 18-21 in Savannah, Ga., highlighted biomarker clinical trials, diabetes and brain research, advances in technology and a program that encouraged emerging experts, say World Molecular Imaging Society leaders in an exclusive interview with Molecular Imaging.

Use of 99mTc-tilmanocept (Lymphoseek, Navidea Biopharmaceuticals) as a SPECT/CT agent can improve preoperative sentinel lymph node localization before surgical treatment for oral cavity squamous cell carcinoma (OSCC), according to a study published in the September issue of JAMA Otolaryngology – Head & Neck Surgery.

Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval for the PillCam SB 3 system. The innovative technology in this third-generation system will provide physicians throughout Japan, the world's second largest healthcare market, with the most advanced PillCam capsule endoscopy technology to detect and monitor small bowel diseases, such as Crohn's disease.

According to the Alzheimer's Disease International 2013 World Alzheimer's Report, "Journey of Caring," care associated with Alzheimer's disease and other forms of dementia is a global issue that must be addressed as prevalence and costs continue to soar, placing enormous stress on families and nations alike.

Viztek, the leading provider of complete orthopaedic digital software and hardware diagnostic imaging solutions, announced today that Excel Orthopaedic Specialists, Woburn, Mass., has completed installation of two Viztek U-Arm DR systems. Completely replacing its existing CR rooms with the Viztek DR, the growing practice looks to benefit from enhanced throughput to accommodate increased patient volume and provides enhanced workflow for technologists and patients.

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved PET radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.

Metastatic breast cancers positive for HER2 receptor expression can be effectively imaged with Cu-64 DOTA-trastuzumab, traditionally used as a therapeutic drug, according to a study published online Sept. 12 in the Journal of Nuclear Medicine.